0 CHECKOUT

PRODUCT FILTERS

REGION

19
1
1
1
1

COUNTRY

1

CATEGORIES

  • 11
  • 8
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

5
6
10
29

PUBLISHED

1
1
1
29

PRODUCT TYPE

23
5
1

Search for: "Pharmexa A/S-Company Report"

29 Products

Pharmexa Acquisition Manual

The Acquisition Manual on Pharmexa is published for two purposes, firstly to identify the company as a potential acquisition target and secondly, to fully analyse all aspects of Pharmexa so that potential...

Published:  September 2015
Price: 

Pancreatic Cancer Drugs - Global Strategic Business Report

This report analyzes the Global market for Pancreatic Cancer Drugs in US$ Million Annual forecasts are provided for the period 2006 through 2015 The report profiles 57 companies including Abraxis BioScience,...

Published:  April 2010
Price:  From

Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape

“Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotech Clusters, Funding Characteristics and Regulatory Landscape ” report provides an overview of the small and medium...

Published:  February 2010
Price:  From

Vaccines: The World Market

What are the trends that are fueling a new boom in vaccine production and sales? Why is an industry so commonly associated with children finding an increasing marketplace among adult populations? ...

Published:  February 2007
Price:  From

Cancer Vaccines: Measuring Market Potential

This brand new report published in October 2004 provides an overview of the emerging market for cancer vaccines and measures their potential impact on a number of cancer markets. Vaccine product...

Published:  October 2004
Price:  From

Infectious Vaccines Partnering Terms and Agreements

The Infectious Vaccines Partnering Terms and agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals...

Published:  December 2013
Price:  From
Infectious Vaccines Partnering Terms and Agreements Infectious Vaccines Partnering Terms and Agreements - Product Thumbnail Image

Bladder Cancer Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual estimates...

Published:  October 2010
Price:  From

Cancer Peptides: From First-in-Class to Best-in-Class?

This report gives you a new and unique way of stratifying and analyzing the global peptide pipeline in cancer towards personalized medicine and presents actionable analysis which allows you to discover:...

Published:  January 2013
Price:  From

A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 companies, from Ceased to Marketed The report extensively analyses their...

Published:  March 2011
Price:  From

Human Vaccines - Global Strategic Business Report

This report analyzes the worldwide markets for Prophylatic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines The report...

Published:  March 2012
Price:  From

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing pancreatic cancer drug development Find out whether you are number one, two or further down the ladder...

Published:  March 2012
Price:  From

Commercializing Peptides in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing peptide drug development in cancer Find out whether you are number one, two or further down the ladder...

Published:  November 2011
Price:  From

Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market

This report comprises defined and up to date development strategies for 416 lung cancer drugs within the portfolio of 217 companies, from Ceased to Marketed The report extensively analyses their 241...

Published:  July 2011
Price:  From

Cancer Vaccines: From First-in-Class to Best-in-Class?

This report gives you a new and unique way of stratifying and analyzing the global cancer vaccine pipeline and presents actionable analysis which allows you to discover: - Where the competition is;...

Published:  March 2013
Price:  From
Cancer Vaccines: From First-in-Class to Best-in-Class? Cancer Vaccines: From First-in-Class to Best-in-Class? - Product Thumbnail Image

The Emerging Cancer Vaccine Market, 2nd Edition

Propelled by advances in molecular biology, the cancer vaccine industry is poised for unprecedented growth. This second edition of Kalorama’s groundbreaking 2003 study completely updates the market...

Published:  November 2006
Price:  From

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

Published:  October 2011
Price:  From

Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing breast cancer drug development Find out whether you are number one, two or further down the ladder...

Published:  August 2012
Price:  From

Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others

This report represents a new and unique way of stratifying and analyzing the global protein kinase drug pipeline in oncology towards personalized medicine It will excel your competitive awareness and...

Published:  May 2012
Price:  From

Drug Delivery Technology - Developing a New Generation of Vaccines

“Over the past year, excitement within the industry has been growing as companies start to recognize the potential of vaccines New insights into immunobiology and delivery systems may allow the development...

Published:  November 2007
Price:  From
Drug Delivery Technology - Developing a New Generation of Vaccines Drug Delivery Technology - Developing a New Generation of Vaccines - Product Thumbnail Image

Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising...

Published:  June 2009
Price:  From
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation